MetLife (NYSE:MET – Get Free Report) will be releasing its earnings data after the market closes on Wednesday, October 30th. Analysts expect MetLife to post earnings of $2.23 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, topping the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The business had revenue of $17.82 billion during the quarter, compared to analysts’ expectations of $18.57 billion. During the same quarter last year, the business posted $1.94 EPS. The business’s revenue was up 7.2% on a year-over-year basis. On average, analysts expect MetLife to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.
MetLife Price Performance
MET opened at $83.07 on Tuesday. The stock’s 50 day moving average price is $80.00 and its 200-day moving average price is $74.60. MetLife has a 52-week low of $58.48 and a 52-week high of $86.94. The stock has a market capitalization of $59.07 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 0.70 and a beta of 1.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the stock. TD Cowen began coverage on shares of MetLife in a research note on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price on the stock. Bank of America cut their price objective on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. JPMorgan Chase & Co. increased their target price on MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 2nd. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. Finally, Wells Fargo & Company raised their price objective on MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.46.
View Our Latest Stock Report on MET
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- How to Most Effectively Use the MarketBeat Earnings Screener
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Oil Stocks to Watch Before Earnings Come Out
- The 3 Best Blue-Chip Stocks to Buy Now
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.